Increasing Biopharmaceutical Pipeline
The growing global biopharmaceutical pipeline, particularly in regions such as monoclonal antibodies, vaccines, and cell and gene therapies, is a major driver of growth for single-use bioreactors. Biologics are becoming increasingly essential in the treatment of chronic diseases, such as cancer & autoimmune disorders. Increased demand requires efficient, flexible, and scalable manufacturing solutions, which single-use bioreactors easily meet by minimizing the time and expense associated with cleaning and sterilization, thereby speeding up drug development and manufacture.
Cost-efficiency and Operational Flexibility
Single-use bioreactors offer significant cost reduction and operational flexibility compared to conventional stainless-steel systems. They eliminate the need for expensive cleaning-in-place (CIP) and sterilization-in-place (SIP) operations, resulting in savings on water, energy, labor, and downtime between batches. This enables faster changeovers and higher throughput, which is especially valuable for CMOs and smaller biotech companies working with varied product portfolios and different batch sizes. Research indicates that single-use systems have the potential to deliver more than 60% cost savings compared to fixed-asset stainless steel bioreactors, based on lower lifetime operating expenses and higher uptime.
Rise of Personalized Medicine
The emerging trend towards precision therapies & personalized medicine offers a huge opportunity to the single-use bioreactor market. These therapies generally have smaller, more flexible batch sizes and shorter cycle times, for which single-use bioreactors are well-suited. Personalized medicine is anticipated to grow significantly, leading to an increasing need for highly flexible manufacturing platforms. The fact that SUBs can be easily switched from one cell line and product to another with little cross-contamination risk is perfect for the highly heterogeneous and often small-batch process of producing personalized medicines.
Improvements in Cell and Gene Therapy Production
The fast growth and innovation in the cell and gene therapy market are generating tremendous opportunities for single-use bioreactors. These advanced treatments, which often involve sensitive cell cultures, greatly benefit from the aseptic and contamination-control attributes of single-use systems. The global cell & gene therapy market is seeing heavy investments and clinical trials. For instance, more than 700 cell and gene therapy trials were active in 2023, increasing the need for flexible and scalable bioreactors. The fact that SUBs can be scaled up from research to clinical & commercial manufacturing levels, accommodating sensitive biological materials, positions them as key players in producing these innovative treatments economically and safely.
The following Key Market Indicators present a comprehensive overview of the social and economic landscape of the selected region, offering critical insights into market-specific trends and developments. These indicators, combined with data from government statistics, industry associations, and corporate sources, form the analytical foundation of NextGen Intelligence Stats' market models.
| Aspects | Details |
Base Year
|
2024 |
Historic Data
|
2021-2023 |
Forecast Period
|
2025-2035 |
Regions & Countries Covered
|
North America (United States, Canada), Europe (Germany, France, Italy, United Kingdom, Spain, Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Rest of Asia Pacific), Latin America (Brazil, Argentina, Rest of Latin America), Middle East& |
Companies Profiles
|
Others |
Segmentation Level Customization
|
|
Company Level Customization
|
|
Country level Data Customization
|
Segmental volume analysis Pricing Analysis of Product Company Market Share |
The Single-Use Bioreactors market is characterized by competition among a select group of major players & several specialist suppliers, creating a dynamic & innovation-focused environment. The competitive tactics are typically centered on product differentiation, enhanced sensor integration, focusing on improved scalability, automation features, and affordability. Players such as Thermo Fisher Scientific, Sartorius AG, and Danaher Corporation (with subsidiaries including Cytiva & Pall Corporation dominate the market with their vast product lines, robust global distribution networks, and ongoing research and development (R&D) investments. These major players offer a range of single-use bioreactor systems, bags, and ancillary products that cater to various bioprocessing applications, spanning from research to commercial production.
• Thermo Fisher Scientific
• Sartorius AG
• Eppendorf AG
• Merck KGaA
• GE Healthcare
• Danaher Corporation
• Pall Corporation
• Repligen Corporation
• Lonza Group
• ABEC
• Others
The global Single-Use Bioreactor market size accounted for USD 8234.9 million in 2024 and it is expected to reach around USD 35354.3 million by 2035.
The global Single-Use Bioreactor market is poised to grow at a CAGR of 12.7% from 2025 to 2035.
North America dominated with 32.8% share in the single-use bioreactors market in 2024.
Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Merck KGaA, GE Healthcare, Danaher Corporation, Pall Corporation, Repligen Corporation, Lonza Group, ABEC and Others.
Increasing Biopharmaceutical Pipeline, Cost-efficiency and Operational Flexibility, Rise of Personalized Medicine, Improvements in Cell and Gene Therapy Production.
In 2024, North America dominated with 32.8% share in the single-use bioreactors market.
1.1. Introduction
1.2. Report Description & Objective
1.3. Assumption And Limitation
2.1. Data Collection
2.2. Primary Research & Secondary Research
2.3. Bottom-Up Approach & Top-Down Approach
2.4. Market Analysis & Size Estimation
2.5. Quality Check & Final Review
3.1. Report Scope
3.2. Executive Summary
4.1. Top Trends To Watch
4.2. Top Strategies Followed By Key Players
4.3. Top Investment Pockets
5.1. Market Definition
5.2. Market Drivers
5.3. Market Restraints & Challenges
5.4. Market Opportunities
6.1. Porter’s Five Forces’ Analysis
6.2. Value Chain Analysis / Supply Chain Analysis
6.3. PESTLE Analysis
6.4. Regulatory Landscape
6.5. Pricing Analysis
7.1. Global Single-Use Bioreactors Market, By Product
7.2. Global Single-Use Bioreactors Market Attractiveness, By Product
7.2.1. Single-Use Bioreactor Systems
7.2.2. Single-Use Media Bags
7.2.3. Single-Use Filtration Assemblies
7.2.4. Others
8.1. Global Single-Use Bioreactors Market, By Type
8.2. Global Single-Use Bioreactors Market Attractiveness, By Type
8.2.1. Stirred-Tank
8.2.2. Wave-Induced
8.2.3. Bubble Column
8.2.4. Others
9.1. Global Single-Use Bioreactors Market, By Cell Type
9.2. Global Single-Use Bioreactors Market Attractiveness, By Cell Type
9.2.1. Mammalian Cell
9.2.2. Bacterial Cell
9.2.3. Yeast Cell
9.2.4. Others
10.1. Global Single-Use Bioreactors Market, By End Use
10.2. Global Single-Use Bioreactors Market Attractiveness, By End Use
10.2.1. Pharmaceutical & Biopharmaceutical Companies
10.2.2. CROs & CMOS
10.2.3. Academic & Research Institutes
11.1. Global Single-Use Bioreactors Market, By Geography
11.2. Global Single-Use Bioreactors Market Attractiveness, By Geography
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Middle East & Africa
11.2.5. Latin America
12.1. North America Market Overview, By Countries
12.2. Market Overview, By Type
12.3. Market Overview, By Product
12.3.1. United States
12.3.2. Canada
13.1. Europe Market Overview, By Countries
13.2. Market Overview, By Type
13.3. Market Overview, By Product
13.3.1. Germany
13.3.2. France
13.3.3. UK
13.3.4. Italy
13.3.5. Spain
13.3.6. Rest of Europe
14.1. Asia Pacific Market Overview, By Countries
14.2. Market Overview, By Type
14.3. Market Overview, By Product
14.3.1. India
14.3.2. China
14.3.3. Japan
14.3.4. South Korea
14.3.5. Rest of Asia Pacific
15.1. Middle East & Africa Market Overview, By Countries
15.2. Market Overview, By Type
15.3. Market Overview, By Product
15.3.1. GCC
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
16.1. South America Market Overview, By Countries
16.2. Market Overview, By Type
16.3. Market Overview, By Product
16.3.1. Brazil
16.3.2. Argentina
16.3.3. Rest of South America
17.1. Key Developments
17.1.1. Partnerships, Collaborations, Agreements
17.1.2. Mergers & Acquisitions
17.1.3. New Product Developments
17.1.4. Other Developments
17.2. Company Share Analysis
17.3. Company Profiles
17.3.1. Thermo Fisher Scientific
17.3.1.1. Company Overview
17.3.1.2. Product Overview
17.3.1.3. Financial Insights
17.3.1.4. Recent Developments
17.3.1.5. SWOT Analysis
17.3.2. Sartorius AG
17.3.3. Eppendorf AG
17.3.4. Merck KGaA
17.3.5. GE Healthcare
17.3.6. Danaher Corporation
17.3.7. Pall Corporation
17.3.8. Repligen Corporation
17.3.9. Lonza Group
17.3.10. ABEC
Data Collection
Primary Research & Secondary Research
Bottom-Up Approach & Top-Down Approach
Market Analysis & Size Estimation
Quality Check & Final Review
By Product
• Single-Use Bioreactor Systems
• Single-Use Media Bags
• Single-Use Filtration Assemblies
• Others
By Type
• Stirred-Tank
• Wave-Induced
• Bubble Column
• Others
By Cell Type
• Mammalian Cell
• Bacterial Cell
• Yeast Cell
• Others
By End Use
• Pharmaceutical & Biopharmaceutical Companies
• CROs & CMOS
• Academic & Research Institutes
© NextGen Intelligence Stats and Consulting LLP All rights reserved.
